Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Diana Basali"'
Publikováno v:
Cancer Research. 82:P5-14
Background: Delays in cancer care can have a detrimental impact on breast cancer outcomes. Despite advances in breast cancer treatment and improvements in survival, disparities between racial groups persist. At our own institution, we observed worse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78aeee99996a7578ea6a77bccd9e9f7e
https://doi.org/10.1158/1538-7445.sabcs21-p5-14-13
https://doi.org/10.1158/1538-7445.sabcs21-p5-14-13
Autor:
Janice Reed, Kristen Schlueter, Lisa Rybicki, M. A. Karam, Nathaniel Rosko, Jason Valent, Matt Kalaycio, Rajshekhar Chakraborty, Hayley Dysert, Diana Basali
Publikováno v:
British Journal of Haematology. 189:1136-1140
The treatment for relapsed/refractory multiple myeloma (RRMM) continues to be challenging despite recent therapeutic advancements. Venetoclax, an inhibitor of the anti-apoptotic protein BCL-2, is a promising agent, especially in patients harbouring t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82027100b3e0d10cc1cfaa35e94d21d5
https://doi.org/10.1111/bjh.16454
https://doi.org/10.1111/bjh.16454
Autor:
Diana Basali, Emily Craig Zabor, Jacob Lindberg, Brittany Peterre, Jacqulyn Tomer, Halle C. F. Moore
Publikováno v:
Journal of Clinical Oncology. 40:e18583-e18583
e18583 Background: Delays in breast cancer treatment have been associated with adverse outcomes. Previously, we observed longer time to treatment initiation (TTT) and inferior overall survival (OS) among Black versus White patients with breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7276bdf7ee38822b85219d3640fca24e
https://doi.org/10.1200/jco.2022.40.16_suppl.e18583
https://doi.org/10.1200/jco.2022.40.16_suppl.e18583
Autor:
Danai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, Bennett Osantowski, Ramsha Ahmed, Diana Basali, Fatimah Chamseddine, Donald Matthew Eicher, Jung Min Song, Brian Gastman, Lucy Boyce Kennedy, Pauline Funchain
Publikováno v:
Journal of Clinical Oncology. 40:e21578-e21578
e21578 Background: Both immunotherapy (IO) and targeted therapy (TT) are approved as adjuvant (Adj) treatment for stage III melanoma, as they have proven to significantly decrease disease recurrence. While there is evidence to suggest overall surviva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4a9ee2b0da5d5cc5e677165653fac09
https://doi.org/10.1200/jco.2022.40.16_suppl.e21578
https://doi.org/10.1200/jco.2022.40.16_suppl.e21578
Publikováno v:
Blood. 136:32-32
Background: Light Chain (AL) amyloidosis is the most common form of systemic amyloidosis and refers to the deposition of abnormally folded monoclonal light chains or their fragments which can cause organ dysfunction. While treatment with autologous s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fad0e80b5e5ea39993ec850a20b6f858
https://doi.org/10.1182/blood-2020-140619
https://doi.org/10.1182/blood-2020-140619
Autor:
Janice Reed, Hayley Dysert, Kristen Schlueter, Matt Kalaycio, Jason Valent, Diana Basali, Kimberly Hamilton, Lisa Rybicki, Rajshekhar Chakraborty, Beth Faiman, Mary Ann Karam, Nathaniel Rosko
Publikováno v:
Blood. 134:5566-5566
Background: Venetoclax is an orally bioavailable inhibitor of the anti-apoptotic protein Bcl-2. In Multiple Myeloma [MM] characterized by t[11;14], it is particularly effective with a single-agent response rate of 40%. However, there have been recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9ba9b06d0c2231d5f198cc8b29a9c1d
https://doi.org/10.1182/blood-2019-129002
https://doi.org/10.1182/blood-2019-129002
Autor:
Anita B Hjlemeland, Diana Basali, Ofer Reizes, Stephen D. Hursting, Nathan A. Berger, Qiao Zheng, Justin D. Lathia, Sarah L. Fracci, Amit Vasanji, Sarah M. Dunlap, Jeremy N. Rich, Lauren Banaszak
Publikováno v:
Endocrine-Related Cancer. 20:797-808
Despite new therapies, breast cancer continues to be the second leading cause of cancer mortality in women, a consequence of recurrence and metastasis. In recent years, a population of cancer cells has been identified, called cancer stem cells (CSCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec70b2145e0c3c13d6b113f47e1b678c
https://doi.org/10.1530/erc-13-0329
https://doi.org/10.1530/erc-13-0329
Autor:
Diana Basali, Richard A. Prayson
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 22(11)
We report a 50-year-old woman who presented with a 20 year history of gradually progressive lower extremity weakness, characterized by knee buckling with occasional falls and foot dragging. She also experienced difficulty in lifting her arms above he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c7e6acd09f1336761155aa9ef6cb242
https://pubmed.ncbi.nlm.nih.gov/26190219
https://pubmed.ncbi.nlm.nih.gov/26190219